 |
|
Increased Neurofilament Light Chain Is Associated with Increased Risk of Long-Term Mortality in Cerebral Small Vessel Disease
Mina A. Jacob, Nils Peters, Mengfei Cai, Marco Duering, Stefan T. Engelter, Jens Kuhle, Frank-Erik de Leeuw, Anil M. Tuladhar
J Stroke. 2022;24(2):296-299. Published online 2022 May 31 DOI: https://doi.org/10.5853/jos.2021.04385
|
|
Citations to this article as recorded by
 NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease
Annelise E. Wilms, I. de Boer, N. Pelzer, S. G. J. G. in’t Veld, H. A. M. Middelkoop, C. E. Teunissen, G. M. Terwindt
Journal of Neurology.2024;[Epub] CrossRef Neurofilaments as biomarkers in neurological disorders — towards clinical application
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, Markus Otto, Fredrik Piehl, Tjalf Ziemssen, Stefan Bittner, Maria Pia Sormani, Thomas Gattringer, Samir Abu-Rumeileh, Simon Thebault, Ahmed Abdelhak, Ari Green, Pascal Benkert, Ludwig Kappos, Manuel
Nature Reviews Neurology.2024;[Epub] CrossRef Elevated Serum Neurofilament Light Chain Levels Are Associated With All-Cause Mortality: Evidence From National Health and Nutrition Examination Survey
Xiaotong Chen, Yong Lin, Kai Wei, Roger Fielding
The Journals of Gerontology: Series A.2023; 78(12): 2382. CrossRef Neurofilaments in neurologic disorders and beyond
Gloria Mak, Suresh Menon, Jian-Qiang Lu
Journal of the Neurological Sciences.2022; 441: 120380. CrossRef
|